Dihydrocodeine
| Material: | 1 ml serum |
| Methods: | Gaschromatographie (GC-MS/MS) → GC-Tandem-Massenspektrometrie |
| Indication | Therapeutic drug monitoring |
| Therapeutic range | 50 µg/l – 150 µg/l |
| Please note | Dihydrocodeine is an opioid analgesic and is primarily used as an antitussive, as it only has a weak analgesic- but a strong cough-reducing effect. Side effects are opiate-/opioid-typical (Sleepiness, constipation, nausea). Caution: Dependency potential! |
| Accredited | ja |
More Results for the letter D
- D-dimers (FSP)
- Fibrin split products
- DDE/DDT (DDT)
- Dengue-virus infection (DENGUE)
- Arboviruses
- Dermatophyte infection (DERM)
- skin mycosis: superficial and deep Trichophyton infections; Microsporon - superficial infections; Epidermophyton infections
- Dermatophytes infection (MDERM)
- Skin fungus, onychomycosis, tinea
- Desipramine (DES)
- Desoxycortisol (11-) (11D)
- DHEAS (DHEA)
- Dehydroepiandrosterone-sulfate
- Diamine oxidase (DAO)
- Diazepam (DIAZ)
- Dibucaine number (DIBUC)
- Cholinesterase variants
- Digitoxin (DIGI)
- Digoxin (DIGO)
- Dihydrocodeine (DIHYD)
- Diphenhydramine (HPLC) (DIPHHY)
- Diphtheria (DIPH)
- Corynebacterium diphtheriae
- Diphyllobothrium latum (APARA)
- Fish tapeworm
- DNA antibodies (DNAA)
- Donath-Landsteiner antibodies (KAEA37)
- Paroxysmal cold hemoglobinuria
- Doxepin (DOX)
- DPD gene analysis (DPDG)
- Dihydropyrimidine dehydrogenase
- DPD-gene analysis (DPD)
- Dihydropyrimidine dehydrogenase
- Drinking water, analysis (DRIN)
- Drug screening in hair (HAARM)
- Drug screening in saliva (SPEIL)
- Drug screening in urine (DRU1-3)
- Duloxetine (DULO)
- Dysbacteria (DYSB)